Lyme disease & co-infections: role of adaptive immune system

References

• 1 Johnson L, Wilcox S, Mankoff J, Stricker RB. Severity of chronic Lyme disease compared with other chronic conditions: a quality of life survey. Peer J. 27(2), e322 (2014).
  Google Scholar
• 2 Feng J, Zhang S, Shi W, Zhang Y. Ceftriaxone pulse dosing fails to eradicate biofilm-like microcolony B. burgdorferi persisters which are sterilized by daptomycin/doxycycline/cefuroxime without pulse dosing. Front. Microbiol. 7(4), 1744 (2016).
  MedlineGoogle Scholar
• 3 Citera M, Freeman PR, Horowitz RI. Empirical validation of the Horowitz multiple systemic infectious disease syndrome questionnaire for suspected Lyme disease. Int. J. Gen. Med. 10(4), 249–273 (2017).
  MedlineGoogle Scholar
• 4 Brorson O, Brorson SH. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection 25(4), 240–246 (1997).
  Medline CASGoogle Scholar
• 5 Sapi E, Kaur N, Anyanwu S et al. Evaluation of in vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect. Drug. Resist. 4, 97–113 (2011).
  Medline CASGoogle Scholar
• 6 Widhe M, Jarefors S, Ekerfelt C et al. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J. Infect. Dis. 189(10), 1881–1891 (2004).
  Medline CASGoogle Scholar
• 7 Elsner RA, Hastey CJ, Olsen KJ, Baumgarth N. Suppression of long-lived humoral immunity following Borrelia burgdorferi infection. PLoS Pathog. 11(7), e1004976 (2015).
  MedlineGoogle Scholar
• 8 Leeflang MM, Ang CW, Berkhout J et al. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC Infect. Dis. 25(16), 140 (2016).
  Google Scholar
• 9 Cook MJ, Puri BK. Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy. Int J. Gen. Med. 9, 427–440 (2016).
  Medline CASGoogle Scholar
• 10 Nanotrap. Magni R, Espina BH et al. Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis. J. Transl. Med. 13, 346 (2015).
  MedlineGoogle Scholar
• 11 Bil-Lula I, Matuszek P, Pfeiffer T, Woźniak M. Lyme borreliosis – the utility of improved real-time PCR assay in the detection of Borrelia burgdorferi infections. Adv. Clin. Exp. Med. 24(4), 663–670 (2015).
  MedlineGoogle Scholar
• 12 Domingues A, Sartori A, Valente LM, Golim MA, Siani AC, Viero RM. Uncaria tomentosa aqueous-ethanol extract triggers an immunomodulation toward a Th2 cytokine profile. Phytother. Res. 25(8), 1229–1235 (2011).
  MedlineGoogle Scholar
• 13 Jin C, Roen DR, Lehmann PV, Kellermann GH. An enhanced ELISPOT assay for sensitive detection of antigen-specific T cell responses to Borrelia burgdorferi. Cells 2(3), 607–620 (2013).
  Medline CASGoogle Scholar
• 14 Masters E, Lynxwiler P, Rawlings J. Spirochetemia after continuous high-dose oral amoxicillin therapy. Infect. Dis. Clin. Pract. 3(3), 207–208 (1994).
  Google Scholar
• 15 Murgia R, Cinco M. Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS 112(1), 57–62 (2004).
  Medline CASGoogle Scholar
• 16 Lawrence C, Lipton RB, Lowy FD, Coyle PK. Seronegative chronic relapsing neuroborreliosis. Eur. Neurol. 35(2), 113–117 (1995).
  Medline CASGoogle Scholar
• 17 Clarissou J, Song A, Bernede C et al. Efficacy of a long-term antibiotic treatment in patients with a chronic tick associated poly-organic syndrome (TAPOS). Med. Mal. Infect. 39(2), 108–115 (2009).
  Medline CASGoogle Scholar
• 18 Stricker RB. Counterpoint: long term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin. Infect. Dis. 45(2), 149–157 (2007).
  Medline CASGoogle Scholar
• 19 Sapi E, Kaur N, Anyanwu S et al. Evaluation of in vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect. Drug Resist. 4, 97–113 (2011).
  Medline CASGoogle Scholar